MAM
ASCI to investigate violation of code of medical ethics
MUMBAI: Medical Council of India (MCI) backs Advertising Standards Council of India (ASCI) for taking action against doctors whose advertisements violate the Medical Code of Ethics Regulations 2002.
In its letter, The Ethics Committee of MCI has strongly backed ASCI for its efforts and self-regulatory mechanism of ensuring ethical advertising practices.
ASCI has observed and processed a large number of complaints of health care products, services and clinic advertisements which has mention of or promotions of doctors. As per MCI rules, doctors cannot promote themselves in advertisements. As an immediate action, ASCI reported to MCI a list of such doctors who were resorting to advertisements in newspapers and on Television and also making misleading, false and unsubstantiated claims. As a response to that, MCI has directed ASCI to send them a state wise list of Allopathic doctors registered with MCI/SMC who have been advertising their products or services so that appropriate action can be taken.
MCI has also directed ASCI to refer to the Indian Medical Registry for obtaining details of doctors making misleading claims in their advertisements and have instructed State Medical Councils (SMC) to further investigate and take action against doctors who do not follow the Medical Council (professional conduct, etiquette & ethics) Regulations, 2002 within a period of six months. This would help MCI to take required action in accordance with the code of Medical Ethics. MCI also sought help from the ASCI to report advertisements by fake doctors to appropriate Law Enforcing Authorities of the Country.
According to ASCI chairman Narendra Ambwani, “This is an important landmark for ASCI in our efforts for protecting the consumers from misleading advertising. Medical Council of India has been very supportive and has advised ASCI to ensure strict action against allopathic doctors who malign the image of medical professionals and violate the Medical Code of Ethics’.
Brands
Safex Group appoints Richa Malhotra as group chief financial officer
Former Standard Chartered executive to steer finance
NEW DELHI: Safex Chemicals has appointed Richa Malhotra as group chief financial officer, strengthening its leadership team as the company prepares for the next phase of expansion in specialty chemicals and global agrochemicals.
In her new role, Malhotra will lead the group’s financial strategy, capital architecture and governance framework as Safex scales operations across multiple verticals including branded formulations, specialty chemicals and contract manufacturing.
A chartered accountant and graduate of Shri Ram College of Commerce, University of Delhi, Malhotra brings more than two decades of experience in business finance, strategic planning, corporate banking and client management.
Before joining Safex, she served as executive director, financial markets at Standard Chartered, where she led teams across India and Sri Lanka and worked closely with large corporates, global subsidiaries and commercial banking clients. Her expertise includes capital structuring, treasury operations, risk management and financial markets led financing solutions.
Safex Group promoter director and joint managing director Piyush Jindal, said the appointment comes at a pivotal time for the company. “Safex stands at an inflection point as we build an integrated platform across branded formulations, specialty chemicals and contract manufacturing. Richa’s experience across global financial institutions will strengthen our financial discipline and help unlock value across the group,” he said.
Malhotra said she was looking forward to contributing to the company’s next chapter of growth. “Safex has built a strong reputation over 35 years with its focus on integrity, innovation and agricultural insight. I am excited to be part of the organisation as it expands its footprint in India and global markets,” she said.
The appointment comes as Safex continues to strengthen its financial foundations and scale operations internationally, positioning itself for future growth milestones.
